Elekta

Last updated
Elekta AB
Type Public
Nasdaq Stockholm:  EKTA B
Industry Neuroscience Radiation therapy Radiosurgery Oncology Electronic medical record
Founded1972  OOjs UI icon edit-ltr-progressive.svg
Founder Lars Leksell, Laurent Leksell
Headquarters,
Sweden
Number of locations
Elekta has over 40 offices globally. Primary locations include: Stockholm, Crawley, Veenendaal, Warsaw, Helsinki, Milan, Cairo, Istanbul, New Delhi, Seoul, Beijing, Shanghai, Hong Kong, Tokyo, Sydney, Sunnyvale, California, St Louis, Missouri, Atlanta, Montreal, Mexico City, São Paulo
Key people
Gustaf Salford, CEO
ProductsElekta Unity MR-Linac, Leksell Gamma Knife, Versa HD linear accelerator, Harmony linear accelerator, Brachytherapy products; as well as Oncology Information System (MOSAIQ), Treatment Planning Software (Monaco)
1,157 million SEK (ca. US$ 118 million)
Number of employees
4,700
Website www.elekta.com

Elekta is a global Swedish company that develops and produces radiation therapy and radiosurgery-related equipment and clinical management for the treatment of cancer and brain disorders. Elekta has a global presence in more than 120 countries, with over 40 offices around the world and about 4,700 employees.

Contents

History

Elekta was jointly founded in 1972 by the late Lars Leksell, Professor of Neurosurgery at the Karolinska Institute in Stockholm, Sweden, and his son Laurent (Larry) Leksell, in order to commercialize the development of the Leksell Stereotactic System, and Gamma Knife, which he had been researching since the late 1940s. [1]

Since 1994, the company has been listed on the Nordic Exchange (Nasdaq Stockholm) under the ticker EKTAb. Larry Leksell became Chief Executive Officer of Elekta until 2005, and under his leadership the company expanded into a public medical technology group with more than 3,400 employees worldwide. Larry Leksell remains the chairman of the Board of Elekta. The role of President and CEO has been held by the following:

Acquired companies

Elekta has acquired companies within the industry as well as distributors and service providers. Some of these include: Philips Medical Systems radiotherapy division, [2] IMPAC Medical Systems, Inc., [3] Beijing Medical Equipment Institute (BMEI), [4] 3D Line Medical Systems, [5] CMS, Inc., [6] Nucletron, [7] ProKnow Systems, LLC, [8] Kaiku Health. [9]

Products

Elekta produces a wide range of devices used in stereotactic radiosurgery, a noninvasive procedure used to treat brain disorders such as tumors, arteriovenous malformation (AVM), and some functional diseases. These devices include:

Neurosurgery products

Neurosurgery products, such as the Leksell Stereotactic System, [10] an arc-based stereotactic frame, based on a polar coordinate system, that is fixed to the patient's head when performing minimally invasive stereotactic neurosurgery procedures.

Leksell Gamma Knife, used to treat brain tumors by administering high intensity gamma radiation therapy in a manner that concentrates the radiation over a small volume. The original device was invented in 1967 at the Karolinska Institute in Stockholm, Sweden by Lars Leksell, Romanian-born neurosurgeon Ladislau Steiner, and radiobiologist Börje Larsson from Uppsala University, Sweden. The first Gamma Knife was brought to the United States through an arrangement between US neurosurgeon Robert Wheeler Rand and Leksell and was given to the University of California, Los Angeles (UCLA) in 1979. Today there are more than 330 Leksell Gamma Knife systems installed and used globally. [11]

Linear accelerators

Elekta also produces linear accelerators (linacs) used for external beam radiotherapy (EBRT), the most common form of radiotherapy (radiation therapy). Some of Elekta's linacs include:

Brachytherapy devices

Through the acquisition of Nucletron in 2011, Elekta became the global market leader in brachytherapy devices. These include:

Software

During its 50 years, Elekta has developed and marketed dozens of new products, and owns thousands of patents [16] for neurosurgical and radiation therapy-related technologies.

Environmental, Social, and Governance commitment

Elekta adheres to its Global Environment Policy, striving to manage its environmental impacts throughout the value chain and the life cycle of delivering its products and services, to meet its long-term environmental ambitions and sustainability goals.

Elekta issued the first sustainability-linked bonds in Sweden with a pure social KPI. [17] The funds of SEK 1.5 billion are intended to contribute to increasing the global access of cancer care in underserved markets.

In August 2021, at its Annual General Meeting, Elekta's shareholders approved the Board of Directors’ proposal to establish the Elekta Foundation. [18] The Elekta Foundation's mission is an important part of Elekta's environmental, social, and governance (ESG) strategy and priorities. Its mission is to initiate and support projects and programs in partnership with governments, NGOs and healthcare providers in low- and middle-income countries to improve access to cancer care.[3]

Other relevant documents and links can be found on the Sustainability page of Elekta's website.

Read more in Elekta's In-Depth Sustainability Report from July 2022.

Related Research Articles

<span class="mw-page-title-main">Neurosurgery</span> Medical specialty of disorders which affect any portion of the nervous system

Neurosurgery or neurological surgery, known in common parlance as brain surgery, is the medical specialty concerned with the surgical treatment of disorders which affect any portion of the nervous system including the brain, spinal cord and peripheral nervous system.

<span class="mw-page-title-main">Radiation therapy</span> Therapy using ionizing radiation, usually to treat cancer

Radiation therapy or radiotherapy, often abbreviated RT, RTx, or XRT, is a treatment using ionizing radiation, generally provided as part of cancer therapy to either kill or control the growth of malignant cells. It is normally delivered by a linear particle accelerator. Radiation therapy may be curative in a number of types of cancer if they are localized to one area of the body, and have not spread to other parts. It may also be used as part of adjuvant therapy, to prevent tumor recurrence after surgery to remove a primary malignant tumor. Radiation therapy is synergistic with chemotherapy, and has been used before, during, and after chemotherapy in susceptible cancers. The subspecialty of oncology concerned with radiotherapy is called radiation oncology. A physician who practices in this subspecialty is a radiation oncologist.

<span class="mw-page-title-main">External beam radiotherapy</span> Treatment of cancer with ionized radiation

External beam radiation therapy (EBRT) is a compound word that refers to the use of a collimated beam of ionizing radiation from outside the body to treat a disease.

<span class="mw-page-title-main">Isocentric technique</span>

An isocentric technique is where all beams used in a radiation treatment have a common focus point, a.k.a. the isocenter. Isocentric techniques require less patient repositioning as multiple field arrangements can be delivered with gantry and collimator movements, reducing treatment times.

<span class="mw-page-title-main">Vestibular schwannoma</span> Medical condition

A vestibular schwannoma (VS), also called acoustic neuroma, is a benign tumor that develops on the vestibulocochlear nerve that passes from the inner ear to the brain. The tumor originates when Schwann cells that form the insulating myelin sheath on the nerve malfunction. Normally, Schwann cells function beneficially to protect the nerves which transmit balance and sound information to the brain. However, sometimes a mutation in the tumor suppressor gene, NF2, located on chromosome 22, results in abnormal production of the cell protein named Merlin, and Schwann cells multiply to form a tumor. The tumor originates mostly on the vestibular division of the nerve rather than the cochlear division, but hearing as well as balance will be affected as the tumor enlarges.

Lars Leksell (1907–1986) was a Swedish physician and Professor of Neurosurgery at the Karolinska Institute in Stockholm, Sweden. He was the inventor of radiosurgery.

<span class="mw-page-title-main">Radiosurgery</span> Surgical Specialty

Radiosurgery is surgery using radiation, that is, the destruction of precisely selected areas of tissue using ionizing radiation rather than excision with a blade. Like other forms of radiation therapy, it is usually used to treat cancer. Radiosurgery was originally defined by the Swedish neurosurgeon Lars Leksell as "a single high dose fraction of radiation, stereotactically directed to an intracranial region of interest".

<span class="mw-page-title-main">Stereotactic surgery</span> Medical procedure

Stereotactic surgery is a minimally invasive form of surgical intervention that makes use of a three-dimensional coordinate system to locate small targets inside the body and to perform on them some action such as ablation, biopsy, lesion, injection, stimulation, implantation, radiosurgery (SRS), etc.

<span class="mw-page-title-main">Varian Medical Systems</span> American healthcare company

Varian Medical Systems is an American radiation oncology treatments and software maker based in Palo Alto, California. Their medical devices include linear accelerators (LINACs) and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies software for managing cancer clinics, radiotherapy centers, and medical oncology practices. Varian Medical Systems employs more than 7,100 people at manufacturing sites in North America, Europe, and China and approximately 70 sites globally.

John R. Adler is an American neurosurgeon.

<span class="mw-page-title-main">Tomotherapy</span> Type of radiation therapy

Tomotherapy is a type of radiation therapy treatment machine. In tomotherapy a thin radiation beam is modulated as it rotates around the patient, while they are moved through the bore of the machine. The name comes from the use of a strip-shaped beam, so that only one “slice” of the target is exposed at any one time by the radiation. The external appearance of the system and movement of the radiation source and patient can be considered analogous to a CT scanner, which uses lower doses of radiation for imaging. Like a conventional machine used for X-ray external beam radiotherapy, a linear accelerator generates the radiation beam, but the external appearance of the machine, the patient positioning, and treatment delivery is different. Conventional linacs do not work on a slice-by-slice basis but typically have a large area beam which can also be resized and modulated.

Image-guided radiation therapy is the process of frequent imaging, during a course of radiation treatment, used to direct the treatment, position the patient, and compare to the pre-therapy imaging from the treatment plan. Immediately prior to, or during, a treatment fraction, the patient is localized in the treatment room in the same position as planned from the reference imaging dataset. An example of IGRT would include comparison of a cone beam computed tomography (CBCT) dataset, acquired on the treatment machine, with the computed tomography (CT) dataset from planning. IGRT would also include matching planar kilovoltage (kV) radiographs or megavoltage (MV) images with digital reconstructed radiographs (DRRs) from the planning CT.

<span class="mw-page-title-main">Cobalt therapy</span> Medical use of gamma rays

Cobalt therapy is the medical use of gamma rays from the radioisotope cobalt-60 to treat conditions such as cancer. Beginning in the 1950s, cobalt-60 was widely used in external beam radiotherapy (teletherapy) machines, which produced a beam of gamma rays which was directed into the patient's body to kill tumor tissue. Because these "cobalt machines" were expensive and required specialist support, they were often housed in cobalt units. Cobalt therapy was a revolutionary advance in radiotherapy in the post-World War II period but is now being replaced by other technologies such as linear accelerators.

The CyberKnife System is a radiation therapy device manufactured by Accuray Incorporated. The system is used to deliver radiosurgery for the treatment of benign tumors, malignant tumors and other medical conditions.

Reno CyberKnife is a cancer treatment center in Reno, Nevada specializing in stereotactic radiosurgery. The center is a service of Saint Mary’s Regional Medical Center and is also a part of Saint Mary’s Brain Tumor Center. Reno CyberKnife is the only provider of CyberKnife technology in northern Nevada and frequently treats prostate and lung cancers and brain tumors.

<span class="mw-page-title-main">N-localizer</span>

The N-localizer is a device that enables guidance of stereotactic surgery or radiosurgery using tomographic images that are obtained via computed tomography (CT), magnetic resonance imaging (MRI), or positron emission tomography (PET). The N-localizer comprises a diagonal rod that spans two vertical rods to form an N-shape and permits calculation of the point where a tomographic image plane intersects the diagonal rod. Attaching three N-localizers to a stereotactic instrument allows calculation of three points where a tomographic image plane intersects three diagonal rods. These points determine the spatial orientation of the tomographic image plane relative to the stereotactic frame.

<span class="mw-page-title-main">Jefferson Hospital for Neuroscience</span> Hospital in Pennsylvania, U.S.

Jefferson Hospital for Neuroscience is a hospital in Center City Philadelphia, affiliated with Thomas Jefferson University and Thomas Jefferson University Hospital in Philadelphia. The hospital focuses on treating brain-related diseases and disorders. It is the only hospital of its kind in the Philadelphia area.

Robert Wheeler Rand, was an American neurosurgeon, inventor, and Professor of Neurosurgery in the Department of Neurosurgery at the University of California Los Angeles (UCLA) from 1953 to 1989.

<span class="mw-page-title-main">Jay Loeffler</span> American physician

Jay Steven Loeffler was an American physician at Massachusetts General Hospital where he served as Chair of the Department of Radiation Oncology since 2000. He was the Herman and Joan Suit Professor of Radiation Oncology and Professor of Neurosurgery at Harvard Medical School.

<span class="mw-page-title-main">Laurent Leksell</span>

Laurent Leksell is a Swedish PhD Economics, international business leader and entrepreneur.

References

  1. Ganz, Jeremy C. (2014). The History of the Gamma Knife. Elsevier. pp. 96ff. ISBN   9780444635266.
  2. "Elekta acquiring Philips Medical Systems radiotherapy division in stock-swap". January 18, 2005.
  3. "Elekta AB to Acquire IMPAC Medical Systems, Inc". January 18, 2005.
  4. "Elekta finalizes the acquisition of 80 percent of BMEI". August 24, 2006.
  5. "Elekta finalizes the acquisition of 3D Line Medical Systems". May 3, 2007.
  6. "Elekta completes the acquisition of CMS". March 4, 2008.
  7. "Regulatory approval for Elekta's acquisition of Nucletron". September 13, 2011.
  8. "Elekta fortifies treatment planning offering with acquisition of ProKnow". August 28, 2019.
  9. "Acquisition of Kaiku Health strengthens Elekta Digital offering with personalized digital health interventions". May 19, 2020.
  10. "The Leksell System". Modern Stereotactic Neurosurgery: 27–46 via Springer.
  11. "The Origins and Development of Radiosurgery and the Leksell Gamma Knife". Leksell Radiosurgery. 34: 1–8. 2019. doi:10.1159/000493044.
  12. "Elekta wins clearances for Versa HD upgrade". August 21, 2013.
  13. "Adaptive radiotherapy: The Elekta Unity MR-linac concept". Clin Transl Radiat Oncol. 18: 54–59. September 1, 2019.
  14. "Device that combines MRI and radiation therapy gets OK in Europe". Health Data Management. June 19, 2018.
  15. "Elekta introduces new radiotherapy solution to help address worldwide cancer burden". September 15, 2020.
  16. "Patents Assigned to Elekta AB (publ.)". JUSTIA Patents.
  17. "Elekta's new sustainability-linked bond oversubscribed". December 3, 2021.
  18. "Elekta's Board announces establishment of philanthropic Elekta Foundation". August 26, 2021.